> This is like comparing big pharma with generic manufacturers who can skip the R&D. While these drugs are not 1 to 1 copies, we are still comparing apples to apples, but with a 90% price cut.
Weird! It's almost like distillation is bad for the long-term growth of the industry, just like generic manufacturers would be if they could release the generic versions of drugs 2 weeks after the original R&D completes.
Very strange sentence to include in an article after saying "I don't care at all about distillation" up at the top. Can the author not hear themselves?
Weird! It's almost like distillation is bad for the long-term growth of the industry, just like generic manufacturers would be if they could release the generic versions of drugs 2 weeks after the original R&D completes.
Very strange sentence to include in an article after saying "I don't care at all about distillation" up at the top. Can the author not hear themselves?